Is elective percutaneous coronary intervention a thing of the past?

Editorials
Dr Vijay Shyam Sundar
17/12/2024

Take home messages

  • Cardiovascular disease risk tools remain imprecise. It
    remains unclear how to integrate polygenic risk scores with
    these tools.
  • Integrated risk tools have been evaluated in primary care
    combining genetic risk with other clinical data.
  • Polygenic risk scores can enhance cardiovascular disease
    risk stratification with the potential to impact on preventive
    therapy.
  • Further prospective studies of polygenic risk scores and the
    impact on preventive medications and risk reduction are
    required.